An adaptation of the diabetes prevention program for use with high-risk, minority patients with type 2 diabetes

被引:36
|
作者
Cramer, J. Steven
Sibley, Ralph F.
Bartlett, Donald P.
Kahn, Linda S.
Loffredo, Lisa
机构
[1] SUNY Buffalo, Sch Med & Biomed Sci, Dept Family Med, Tonawanda, NY 14150 USA
[2] Kaleida Hlth, Buffalo, NY USA
来源
DIABETES EDUCATOR | 2007年 / 33卷 / 03期
关键词
D O I
10.1177/0145721707301680
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE The purpose of this pilot study was to determine the effectiveness of an edited Diabetes Prevention Program (DPP) Lifestyle Resources Core Teaching Plan for managing patients with type 2 diabetes in an urban underserved setting. Modifications were made to attempt to cut to the bare essentials to work within the constrained budgets of safety net providers. The primary aim was to achieve a mean absolute reduction in HbA1c level of 1 percentage point. METHODS The authors conducted a randomized controlled trial of 9 months' duration for patients with type 2 diabetes with an HbA1c >= 8.0%. A total of 67 patients randomized into usual-care and case management groups were evaluated with an intention-to-treat analysis. A modified DPP workbook was used during 7 monthly visits with a nurse case manager. RESULTS As compared with the usual-care group, those in the case management group experienced a greater reduction in HbA1c level (-1.87 vs -0.54; P =.011) and weight (-2.47 kg vs +0.88 kg; P =.011). CONCLUSION Use of an edited version of the DPP workbook in an urban, low-income, minority population with type 2 diabetes produced a significant absolute reduction in HbA1c percentage and weight.
引用
收藏
页码:503 / 508
页数:6
相关论文
共 50 条
  • [41] Diagnostic yield of screening for type 2 diabetes in high-risk patients - A systematic review
    Rao, G
    JOURNAL OF FAMILY PRACTICE, 1999, 48 (10): : 805 - 810
  • [42] Putting the diabetes prevention program into practice: A program for weight loss and cardiovascular risk reduction for patients with metabolic syndrome or type 2 diabetes mellitus
    Patrick E. McBride
    J. A. Einerson
    H. Grant
    C. Sargent
    G. Underbakke
    M. Vitcenda
    L. Zeller
    J. H. Stein
    The Journal of Nutrition, Health & Aging, 2008, 12 (10) : 745 - 750
  • [43] Can we prevent high-risk patients from getting type 2 diabetes?
    Evans, MF
    CANADIAN FAMILY PHYSICIAN, 2002, 48 : 279 - 281
  • [44] Patients on atypical antipsychotic drugs: Another high-risk group for type 2 diabetes
    Lean, MEJ
    Pajonk, FG
    DIABETES CARE, 2003, 26 (11) : 3202 - 3203
  • [45] Risk and prevention of type 2 diabetes in women with gestational diabetes
    Dornhorst, A
    Rossi, M
    DIABETES CARE, 1998, 21 : B43 - B49
  • [46] Co-morbidities and polypharmacy in high-risk patients with type 2 diabetes mellitus
    Nwachuku, U
    Woods, KF
    Schlundt, DG
    Hargreaves, MK
    McNeil, L
    Nwokoro, U
    Adeola, T
    Self, I
    DIABETES, 2001, 50 : A499 - A499
  • [47] Patients on atypical antipsychotic drugs - Another high-risk group for type 2 diabetes
    Lean, MEJ
    Pajonk, FG
    DIABETES CARE, 2003, 26 (05) : 1597 - 1605
  • [48] Fasting plasma glucose and new onset of diabetes type 2 in high-risk patients
    Held, C.
    Gerstein, H.
    Zhao, F.
    Hilbrich, L.
    Anderson, C.
    Sleight, P.
    Yusuf, S.
    Teo, K.
    EUROPEAN HEART JOURNAL, 2006, 27 : 520 - 520
  • [49] Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus
    Ebell, Mark H.
    AMERICAN FAMILY PHYSICIAN, 2017, 95 (06) : 396 - 396
  • [50] The Diabetes Prevention Program - Design and methods for a clinical trial in the prevention of type 2 diabetes
    Bray, GA
    Culbert, IW
    Champagne, CM
    Dawson, L
    Eberhardt, B
    Greenway, FL
    Guillory, FG
    Hebert, AA
    Jeffirs, ML
    Kennedy, BM
    Lovejoy, JC
    Morris, LH
    Melancon, LE
    Reed, L
    Perault, J
    Ryan, DH
    Sanford, DA
    Smith, KG
    Smith, LL
    St Amant, JA
    Tulley, RT
    Vicknair, PC
    Williamson, D
    Zachwieja, JJ
    Polonsky, KS
    Matulik, MJ
    Clarke, B
    DeSandre, C
    Ehrmann, DA
    Hilbrich, RM
    McNabb, WL
    Morrone, D
    Semenske, AR
    Stepp, KA
    Tobian, JA
    Watson, PG
    Caro, JF
    Goldstein, BJ
    Graziani, CM
    Kunkel, EJ
    Laine, CA
    Louis, DZ
    Smith, KA
    Spandirfer, J
    Yuen, EJ
    Goldberg, RB
    Rowe, P
    Calles, J
    Donahue, RP
    Florez, HJ
    DIABETES CARE, 1999, 22 (04) : 623 - 634